Addex Therapeutics (ADXN) Price to FCF (2020 - 2026)

Addex Therapeutics has disclosed Price to FCF across 7 years of filings, most recently posting 5.75 for Q1 2026.

• In Q1 2026, Price to FCF rose 36.14% year-over-year to 5.75; the TTM figure through Mar 2026 stood at 1.92 (up 66.76% YoY), while the FY2025 annual figure was 0.3, up 47.95% from the prior year.
• Price to FCF came in at 5.75 for Q1 2026 at Addex Therapeutics, up from 8.91 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 1.82 in Q4 2024 to a low of 122.33 in Q1 2022.
• Average Price to FCF over 5 years is 21.14, with a median of 11.6 recorded in 2025.
• Year-over-year, Price to FCF jumped 538.35% in 2024 and tumbled 808.69% in 2025.
• Over 5 years, Price to FCF stood at 5.56 in 2022, then jumped by 92.52% to 0.42 in 2023, then jumped by 538.35% to 1.82 in 2024, then sank by 588.65% to 8.91 in 2025, then jumped by 35.44% to 5.75 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 5.75 in Q1 2026, 8.91 in Q4 2025, and 11.6 in Q3 2025.